THC compliance stands out as the main concern for hemp farmers in today’s world when it comes to hemp genetics. High CBD yields are essential but keeping a compliant crop that will not run the risk of destruction due to THC content is the most crucial consideration for a farmer. Today we’ll briefly look at cannabinoids, compliance, testing methods, and the importance of having a testing plan with reliable testing partners before you plant.
The U.S. Farm Bill defines hemp as cannabis that contains less than 0.3% total THC by dry weight. THC, CBD’s psychoactive constituent, is classified as a Schedule 1 drug by the Food and Drug Administration and is highly regulated. CBD is non-psychoactive and is not considered a Schedule 1 drug by the FDA and is not regulated (although recent CBD patents by GW Pharma will incur regulation). Interestingly, many modern CBD-rich hemp genetics derive from so-called “drug-type” cannabis strains that once contained high levels of THC. These genetics were bred over generations to minimize THC production and maximize CBD content.
The truth is that many CBD-rich hemp varietals are nearly indistinguishable from their THC-containing “marijuana” sisters. The visual appeal, aroma (terpene content), and structure can be almost identical between two different genotypes, one with THC and one that does not. When I first started breeding with high CBD/low THC genetics in 2011, it was next to impossible to tell the difference in cannabinoid content until we submitted samples to the lab for cannabinoid testing.
I assumed many of the plants would have high THC content that contained very low THC and had high amounts of CBD. Testing laboratories across the U.S. have opened their doors to hemp growers. Now that hemp is legal in all 50 states, farmers can mail their samples to labs in other States if they cannot find a viable alternative locally.
Colorado has several licensed labs that will accept samples mailed from anywhere in the U.S. It is also essential to understand your State’s requirements for THC testing. Some States test for “total THC”, which is Delta9 THC combined with converted THCA, and others test for only Delta9 THC. Also, understanding the testing method used by your State can help determine a testing partner. In Colorado, the Department of Agriculture uses Gas Chromatography (GC) to determine cannabinoid content. As a result, Foundation Seeds performs GC testing in-house and utilizes High-Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) via 3rd party laboratories for confirmation and verification of our in-house results.
What does this mean for you as a CBD hemp farmer? It means you can’t always tell a book by its cover. This makes 3rd party analytical testing paramount to ensuring a successful and compliant crop. We recommend that farmers begin cannabinoid testing once the plants have started flowering every 5-7 days throughout the flowering cycle until harvest. Advanced testing can save you money in avoiding non-compliant crop losses and provide you with valuable crop data to help make informed decisions for the next crop and offer it to a potential buyer or processing partners and commodity traders.
We test all our genetics before releasing and provide our customers with detailed CBD, CBG, and THC cannabinoid maturation curves to understand harvest timelines and cannabinoid content. Our founders bred and have been working with the leading hemp genetics on the market and producing feminized cannabis seeds since 2012.
Eric is the Director of Breeding and Genetics at Catalyst BC. Article originally posted on the Fondation Seeds website.
Additional Resources
Consulting Services For Cannabis, Hemp, Psilocybin, and Natural Medicine
- Consulting Services Overview
- Business Strategy
- Financial Planning
- Cannabis, Hemp, Psilocybin, & Natural Medicine Licensing and Applications
- Facility Design
- StartUp Support
- Genetic Development
- Business Turnaround
- Operational Optimization
- Vertical Farming
- Controlled Environmental Agriculture (CEA)
- State and Country Services Directory
- Blog
- Home
Testimonials and Public Relations
Latest Articles
- The Fiduciary Mandate: Why an Owner’s Rep is the Key to 2026 Cannabis Retail Success
In the cannabis retail landscape of 2026, the era of “opening at any cost” has ended. As capital markets remain disciplined and consumer margins tighten, the difference between a profitable dispensary and a “zombie project” is determined during the buildout phase. - Open a Cannabis Consumption Lounge in New Jersey: 2026 Guide to Compliance and Success
As of April 2026, the New Jersey cannabis market has matured into a sophisticated $4 billion powerhouse. The initial “novelty” phase has passed, and the industry is now defined by “Hospitality 2.0,” where consumption areas are becoming social anchors for local tourism in hubs like Atlantic City, Newark, and Jersey City. - New York Cannabis Lounge License: Expert Guide to Compliance and Success
The New York cannabis industry has transitioned from a volatile implementation phase into a “Pharma-Grade” era of structural maturity. As of April 2026, the state has reached a monumental economic milestone, with total reported retail sales officially surpassing $3,000,000,000. For entrepreneurs, the current frontier is the “social hospitality” sector, which is defined by high-stakes technical compliance and rigorous municipal negotiation. - The 2026 New York Execution Gap: Scaling Your Cannabis Business
The trajectory of the New York cannabis industry has transitioned from a period of experimental regulation to one of massive commercial consolidation and operational intensity. As of April 15, 2026, the state has officially matured into its role as the second-largest cannabis market in the United States, trailing only California in total economic activity and consumer demand. The primary indicator of this success is the milestone reached in early 2026, where total reported retail sales since the inception of the legal program surpassed $2.97 billion. - Regulatory Maturity and Market Dynamics: A Comprehensive Analysis of the New Jersey Cannabis Industry
The legal landscape of cannabis in New Jersey has transitioned from a period of rapid legislative enactment into an era of complex regulatory maturity and secondary market correction. Since the foundational passage of the New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (CREAMMA) in early 2021, the state has systematically dismantled the architecture of prohibition while constructing a highly regulated, billion-dollar industry. - Nebraska Medical Cannabis Market Strategic Report: Navigating the Regulatory Landscape and Licensing Framework 2026
The Nebraska medical cannabis industry has undergone a radical transformation from its nascent beginnings in the 2024 general election to the highly structured, albeit restrictive, regulatory environment of April 2026. This period has been characterized by intense legislative maneuvering, high-stakes licensing competitions, and a fundamental shift in the state’s administrative approach to controlled substances.
Explore Our Articles
cannabis applications Cannabis Bar Cannabis Business Optmization cannabis careers Cannabis Compliance Cannabis Consumption Cannabis Consumption Bar Cannabis Inventory Management Systems Cannabis Investors cannabis jobs Cannabis Legalization cannabis licensing Cannabis Lounge cannabis marketing Cannabis Operational Procedures cannabis outreach Cannabis Regulations Cannabis Security Cannabis Software Cannabis Startup Cannabis Supply Chain Cannabis Technology Colorado controlled environment agriculture Cultivation cultivation facility Dispensary Design facility design Financial Planning HVAC HVACD Iowa Kansas Legal Update Legislation Medical Cannabis Minnesota Natural Medicine Nebraska New York Odor Control Oregon Psilocybin Psychedelics Recreational Cannabis
Free Ebook – Start Your Own Legal Cannabis Business
